Memorial Sloan Kettering Cancer Center: Research
Runtime 12:49
Craig Thompson welcomes high school students to the eighth annual Memorial Sloan Kettering Major Trends in Modern Cancer lecture.
Runtime 28:39
Leukemia expert Omar Abdel-Wahab says new therapies that reverse epigenetics — chemical changes within cells that drive gene expression — are being combined with conventional chemotherapy drugs to silence cancer-causing genes and treat some cancers.
Runtime 30:29
Scientist Emily Foley discusses the mechanics of cell division and its relevance to developing new cancer treatments.
Runtime 29:12
Oncologist and cancer biologist Richard White explains how his research with genetically modified zebrafish, which reproduce quickly and are optically transparent, has shed light on how melanoma and other cancers spread.
Memorial Sloan Kettering President and CEO Craig Thompson along with neuropathologist Jason Huse and immunologist Morgan Huse explain how recent developments contribute to better treatments for cancer patients.
Runtime 34:13
Immunologist Morgan Huse discusses how the orientation of T cells — a type of white blood cell — affects the way they mount an immune response.
Runtime 31:32
Neuropathologist Jason Huse discusses personalized medicine and how studying the molecular pathology of patients’ tumors can lead to new therapies.
Runtime 31:12
Memorial Sloan Kettering President and CEO Craig B. Thompson welcomes attendees to the seventh annual Major Trends in Modern Cancer Research lecture for high school students and introduces the speakers.
Runtime 110:45
Memorial Sloan Kettering President and CEO Craig Thompson along with cancer biologist Andrea Ventura, molecular biologist Iestyn Whitehouse, and developmental biologist Jennifer Zallen explain how recent developments contribute to better treatments for cancer patients.
Runtime 32:00
Craig B. Thompson, President and CEO of Memorial Sloan Kettering Cancer Center, discusses new ways to think about cancer and how cancer arises in human beings.
Runtime 39:00
Physician-scientist Timothy A. Chan discusses cancer genomics at the forefront of cancer research and how developments have allowed researchers to discover what goes wrong in cancer faster than and more thoroughly.
Your feedback is valuable to us. Should you encounter any bugs, glitches, lack of functionality or other problems, please email us on [email protected] or join Moon.FM Telegram Group where you can talk directly to the dev team who are happy to answer any queries.